🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

951 results for “Eli” Clear

  1. Insulin Glargine

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  2. Insulin lispro low mixture

    Eli Lilly and Company

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  3. LETROZOLE, RIBOCICLIB, GOSERELIN ACETATE, LEE011, TAMOXIFEN

    Novartis Pharmaceuticals

    HR+, HER2- advanced or metastatic breast cancer

    approved small molecule active

    1 trial

  4. Leuprorelin

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  5. Leuprorelin Acetate Depot 3M

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  6. Metronidazole

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  7. Niraparib

    Takeda

    Epithelial Ovarian Cancer

    approved small molecule active

    1 trial

  8. Omvoh 100 mg solution for injection in pre-filled syringe, Omvoh 100 mg + 200 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled syringe, Omvoh 100 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solution for injection in pre-filled pen, Omvoh 100 mg + 200 mg solutio

    Eli Lilly Co.

    severely active ulcerative colitis (US) and CD (Crohn’s disease)

    approved small molecule active

    1 trial

  9. Parecoxib

    The First People's Hospital of Lianyungang

    Emergence Delirium

    approved small molecule active

    1 trial

  10. Pethidine

    Stoke Therapeutics

    Pain Relief in Labour

    approved small molecule completed

    1 trial

  11. Pozelimab

    Regeneron UK Limited

    CHAPLE Disease

    approved small molecule active

    1 trial

  12. Quick-Acting Heart Reliever

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Stenosis

    approved small molecule completed

    1 trial

  13. Rocuronium

    ELITE PHARMACEUTICALS INC /NV/

    Muscle Relaxation

    approved small molecule completed

    1 trial

  14. Rocuronium Bromide

    ELITE PHARMACEUTICALS INC /NV/

    Muscle Relaxation

    approved small molecule completed

    1 trial

  15. SELPERCATINIB, SELPERCATINIB

    Eli Lilly Co.

    Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration;

    approved small molecule active

    1 trial

  16. SINECATECHINS

    The George Institute

    Anal high-grade squamous intraepithelial lesions (HSIL).

    approved small molecule active

    1 trial

  17. Satralizumab 120 mg

    Hoffmann-La Roche

    Neuromyelitis Optica Spectrum Disorder

    approved small molecule terminated

    1 trial

  18. Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial

  19. TIMOFEROL 50 mg, comprimé enrobé, TIMOFEROL, gélule, FERRIC CARBOXYMALTOSE

    Pari Pharma GmbH

    Women who delivered by caesarean and have a moderate postpartum iron deficiency anaemia defined by 8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL within 72h after delivery and a ferritinemia ≤ 100 ng/mL OR transferrin saturation ≤ 20% (Measured after postoperative Hb level measurement)

    approved small molecule active

    1 trial

  20. Tislelizumab

    The First People's Hospital of Lianyungang

    Advanced NSCLC

    approved small molecule active

    1 trial

  21. Tislelizumab + cisplatin + paclitaxel

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    approved small molecule active

    1 trial

  22. Trimebutine 100 MG

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  23. VAB-7

    The First People's Hospital of Lianyungang

    Helicobacter Pylori

    approved small molecule active

    1 trial

  24. Vonoprazan

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources